PDS Biotechnology's three largest insider shareholders as of August 04, 2026 are Frank Bedu-Addo (President/Ceo, 690.87K shares), Stephen C. Glover (Director, 78.85K shares), Gregory Gene Freitag (Director, 61.21K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Matthew C Hill | Chief Financial Officer | 3,875 | 8,050 | 14 Dec, 2021 |
| Stephen C. Glover | - | 78,851 | 0 | 03 Mar, 2025 |
| Gregory Gene Freitag | - | 61,213 | 0 | 03 Mar, 2025 |
| Frank Bedu-Addo | President/Ceo | 690,866 | 0 | 02 Dec, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 12 Jan, 2026 | Stephen C. Glover | Employee Stock Option (Right to Buy) | A | 54,876 | $0.00 | 54,876 | D | A |
| 12 Jan, 2026 | Stephan Toutain | Employee Stock Option (Right to Buy) | A | 300,000 | $0.00 | 300,000 | D | A |
| 12 Jan, 2026 | Kirk V. Shepard | Employee Stock Option (Right to Buy) | A | 300,000 | $0.00 | 300,000 | D | A |
| 12 Jan, 2026 | Stephan Toutain | Employee Stock Option (Right to Buy) | A | 300,000 | $0.00 | 300,000 | D | A |
| 12 Jan, 2026 | Otis W Brawley | Employee Stock Option (Right to Buy) | A | 54,876 | $0.00 | 54,876 | D | A |
| 12 Jan, 2026 | Ilian Iliev | Employee Stock Option (Right to Buy) | A | 54,876 | $0.00 | 54,876 | D | A |
| 12 Jan, 2026 | Frank Bedu-Addo | Employee Stock Option (Right to Buy) | A | 548,782 | $0.00 | 548,782 | D | A |
| 12 Jan, 2026 | Gregory Conn | Employee Stock Option (Right to Buy) | A | 150,000 | $0.00 | 150,000 | D | A |
| 12 Jan, 2026 | Spencer D. Brown | Employee Stock Option (Right to Buy) | A | 300,000 | $0.00 | 300,000 | D | A |
| 12 Jan, 2026 | Lars Boesgaard | Employee Stock Option (Right to Buy) | A | 300,000 | $0.00 | 300,000 | D | A |
| 12 Jan, 2026 | Kirk V. Shepard | Employee Stock Option (Right to Buy) | A | 300,000 | $0.00 | 300,000 | D | A |
| 12 Jan, 2026 | Kamil Ali-Jackson | Employee Stock Option (Right to Buy) | A | 54,876 | $0.00 | 54,876 | D | A |
| 12 Jan, 2026 | Kirk V. Shepard | Employee Stock Option (Right to Buy) | A | 300,000 | $0.00 | 300,000 | D | A |
| 12 Jan, 2026 | Gregory Gene Freitag | Employee Stock Option (Right to Buy) | A | 54,876 | $0.00 | 54,876 | D | A |
| 12 Jan, 2026 | Stephan Toutain | Employee Stock Option (Right to Buy) | A | 300,000 | $0.00 | 300,000 | D | A |
| 12 Jun, 2025 | Kirk V. Shepard | Employee Stock Option (Right to Buy) | A | 150,000 | $0.00 | 150,000 | D | A |
| 12 Jun, 2025 | Stephan Toutain | Employee Stock Option (Right to Buy) | A | 150,000 | $0.00 | 150,000 | D | A |
| 12 Jun, 2025 | Kirk V. Shepard | Employee Stock Option (Right to Buy) | A | 150,000 | $0.00 | 150,000 | D | A |
| 12 Jun, 2025 | Kirk V. Shepard | Employee Stock Option (Right to Buy) | A | 150,000 | $0.00 | 150,000 | D | A |
| 12 Jun, 2025 | Stephan Toutain | Employee Stock Option (Right to Buy) | A | 150,000 | $0.00 | 150,000 | D | A |